New research has revealed that women suffering from autoimmune diseases, such as rheumatoid arthritis, lupus, or systemic sclerosis, face a higher risk of dying from cardiovascular disease (CVD) compared to their male counterparts with the same conditions. The findings, published in the American Heart Association’s journal Circulation: Cardiovascular Quality and Outcomes, underscore the significant gender disparity in cardiovascular mortality among patients with these autoimmune diseases.
The Link Between Autoimmune Diseases and Cardiovascular Risk
Immune-mediated inflammatory diseases, including rheumatoid arthritis, lupus, psoriasis, and others, involve chronic inflammation that can contribute to the development of cardiovascular diseases like coronary artery disease and stroke. Previous studies have suggested that individuals with these diseases face increased risks of heart attacks, heart failure, and other heart-related complications. However, research into how these diseases affect women and men differently in terms of cardiovascular mortality has been limited.
According to the National Institute of Allergy and Infectious Diseases, approximately 27 million people in the U.S. have an autoimmune disease, and these diseases are known to contribute to inflammation in the body that can damage blood vessels and lead to cardiovascular disease.
Gender Differences in Cardiovascular Mortality
The recent study, which analyzed data from the CDC WONDER database covering over 127,000 cardiovascular disease-related deaths between 1999 and 2020, explored the cardiovascular mortality rates among men and women with rheumatoid arthritis, lupus, and systemic sclerosis. The findings indicate that:
The cardiovascular disease-related death rate in women with immune-mediated inflammatory diseases decreased over the study period, from 3.9 to 2.1 per 100,000, but women still experienced higher mortality rates compared to men, whose rate decreased from 1.7 to 1.2 per 100,000.
Women with these autoimmune diseases were more likely than men to die from stroke and coronary artery disease.
The risk of death from irregular heart rhythm or cardiac arrest was more than twice as high in women as in men with these conditions.
Specific Autoimmune Diseases and Cardiovascular Risk
The study also found varying cardiovascular disease death rates across different autoimmune diseases. People with rheumatoid arthritis had the highest rate, with 1.8 deaths per 100,000 among women, compared to just 0.6 deaths per 100,000 among men. In contrast, lupus had a much lower death rate, with 0.2 deaths per 100,000 among women and 0.1 deaths per 100,000 among men. The cardiovascular mortality rate for those with systemic sclerosis was too low to compare the gender differences.
Cardiovascular Disease as a Leading Cause of Death
The study revealed a striking fact: one-third of deaths among people with autoimmune diseases were due to cardiovascular disease, highlighting its significant burden on this population. This is especially important given that autoimmune diseases are commonly associated with infections or kidney disease-related deaths, but cardiovascular mortality often goes underrecognized in these patients.
Importance of Gender-Specific Treatment and Research
The findings call attention to the need for more research into the gender disparities in cardiovascular outcomes for individuals with autoimmune diseases. According to Dr. Issam Motairek, the study’s lead author, “This study reinforces the need to investigate drivers of these disparities between women and men and how to improve treatment for patients with immune-mediated inflammatory diseases.”
Future research should aim to explore the mechanisms behind the increased cardiovascular risk in women with these diseases and develop targeted prevention strategies to reduce the risk of cardiovascular mortality. Additionally, better understanding of how inflammation contributes to coronary artery disease in these patients will be critical in improving their long-term health outcomes.
Conclusion
This study underscores the significant cardiovascular risks faced by women with autoimmune diseases like rheumatoid arthritis and lupus, which are compounded by gender-specific factors. Despite overall improvements in mortality rates, women continue to bear a disproportionate burden of cardiovascular disease, making it crucial to develop more effective, tailored treatments and prevention strategies. As we better understand the relationship between chronic inflammation and heart disease, particularly in autoimmune disease patients, healthcare providers can take steps to address these risks and improve health outcomes for this vulnerable population.
You Might Be Interested In:
- Is It Safe to Take Cold Medicine While Breast-Feeding?
- Sore Throat: Allergy or Cold? Plus Treatment and Prevention
- Hypersensitivity Pneumonitis: Causes, Symptoms & Treatment
